(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | |||||||||
Cash flow from continuing operating activities | -1.53M | -796.20%-448.1K | -2,567.19%-3.51M | -1,613.21%-1.6M | -1.86M | -50K | 142.19K | 105.81K | |
Net income from continuing operations | ---1.34M | -15.52%-547.78K | -150.12%-4.39M | -447.04%-1.08M | ---2.09M | ---- | ---474.21K | ---1.76M | ---196.59K |
Operating gains losses | ---- | ---- | -592.31%-180K | ---- | ---- | ---- | ---- | ---26K | --0 |
Depreciation and amortization | --1.37K | 0.06%1.71K | 8.96%6.84K | 0.00%1.71K | --1.71K | ---- | --1.71K | --6.27K | --1.71K |
Unrealized gains and losses of investment securities | ---78K | --69K | --93K | ---- | ---- | ---- | --0 | --0 | ---- |
Remuneration paid in stock | --87.64K | --44.15K | --132.28K | --76.6K | --55.68K | ---- | --0 | --0 | --0 |
Other non cashItems | ---26.2K | -7.99%-30.61K | -1,024.51%-665.82K | 950.80%149.55K | ---756.67K | ---- | ---28.35K | ---59.21K | ---17.58K |
Change In working capital | ---170.52K | -96.58%15.43K | -24.25%1.5M | -309.45%-666.61K | --936.47K | ---- | --450.84K | --1.98M | --318.27K |
-Change in receivables | ---213.5K | 1,280.50%60.26K | -95.94%-117.53K | -59.21%34.66K | ---38.4K | ---- | --4.37K | ---59.98K | --84.99K |
-Change in payables and accrued expense | --42.98K | -135.20%-44.83K | -83.10%15.65K | -91.65%-701.27K | --748.63K | ---- | --127.37K | --92.62K | ---365.92K |
-Change in other working capital | ---- | ---- | -17.74%1.6M | --0 | --226.23K | ---- | --319.11K | --1.94M | --599.2K |
Cash from discontinued investing activities | |||||||||
Operating cash flow | ---1.53M | -796.20%-448.1K | -2,567.19%-3.51M | -1,613.21%-1.6M | ---1.86M | ---- | ---50K | --142.19K | --105.81K |
Investing cash flow | |||||||||
Cash flow from continuing investing activities | 0 | 0.00%50K | -26.91%-180.44K | -96.52%-207.94K | -22.5K | 50K | -142.19K | -105.81K | |
Net PPE purchase and sale | ---- | ---- | -66.65%-230.44K | -170.39%-207.94K | ---- | ---- | ---- | ---138.28K | ---76.91K |
Interest received (cash flow from investment activities) | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --2.09K | ---- |
Net other investing changes | --0 | 0.00%50K | 933.33%50K | --0 | --0 | ---- | --50K | ---6K | ---31K |
Cash from discontinued investing activities | |||||||||
Investing cash flow | --0 | 0.00%50K | -26.91%-180.44K | -96.52%-207.94K | ---22.5K | ---- | --50K | ---142.19K | ---105.81K |
Financing cash flow | |||||||||
Cash flow from continuing financing activities | 4.68M | -66K | 4.75M | 1 | 0 | 0 | |||
Net common stock issuance | ---- | ---- | --4.81M | --613.94K | --4.2M | --1 | ---- | --0 | --0 |
Net other financing activities | ---- | ---- | ---129.37K | ---679.94K | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | |||||||||
Financing cash flow | ---- | ---- | --4.68M | ---66K | --4.75M | --1 | ---- | --0 | --0 |
Net cash flow | |||||||||
Beginning cash position | --593.71K | --991.81K | --0 | --2.87M | --0 | --0 | --0 | --0 | --0 |
Current changes in cash | 304,819,200.00%3.05M | ---398.1K | --991.81K | ---1.88M | ---- | --1 | ---- | ---- | ---- |
End cash Position | 364,190,000.00%3.64M | --593.71K | --991.81K | --991.81K | --2.87M | --1 | --0 | --0 | --0 |
Free cash from | ---1.53M | -796.20%-448.1K | -23,130.02%-3.74M | -6,358.35%-1.81M | ---1.88M | ---- | ---50K | ---16.09K | --28.91K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data